National Comprehensive Cancer Network updates treatment guideline for type of skin cancer
from Journal of Clinical Pathways
The National Comprehensive Cancer Network (NCCN) released updates to its treatment guideline for basal cell skin cancer. In the section for clinical presentation, workup, and risk status, the first statement now reads, “Lesion suspicious for skin cancer.” A pathway was added under risk status: initial presentation of advanced disease. This pathway directs readers to the section for treatment for recurrence or advanced disease. The section for treatment for local, low-risk disease features a minor change. Under adjuvant treatment, the abbreviation “CCPDMA” is listed and defined in the footnotes as “complete circumferential peripheral and deep margin assessment.” This abbreviation is used throughout the guideline.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063